Global investment hotspots & hidden gems – where investors should be looking

Investment in cell and gene therapies (CGT) is increasingly global, with innovation hubs expanding beyond traditional markets. This discussion brings together leading investors to examine where value is emerging, how to evaluate cross-border opportunities, and what factors differentiate regions building sustainable biotech ecosystems. For US-based investors, the conversation extends to assessing global competitiveness, risk management, and long-term growth potential.

Key takeaways

• Key global regions gaining traction in advanced therapy investment
• Assess how geography influences talent access, trial infrastructure, and regulatory pace
• Identify emerging hubs developing robust and investable biotech ecosystems
• Understand regional differences in capital availability and policy support
• Explore strategies for evaluating and managing international investment risk